Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.
Dic corporate group of Japan, India is one of the World's largest manufacturers and suppliers of dainippon ink & chemicals, Printing inks, off set ink, UV ink, chemical solution material with its own R&D center at Kolkata and Noida.
Read latest news about Dic India company profile, Dic Group, Dic Inks, Dic India Limited, Dic Inks India, Dic Corporation and Dic Corporate Group located in Japan and in many states of India.
The report is titled as 'Glioma Treatment Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Glioma Treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.